Atria Investments’s NuVasive, Inc. NUVA Stock Holding History

Atria Investments’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,620	Closed	-$203K	–	1244
2019 Q4	$203K	Buy	+2,620	New	+$185K	0.01%	1150

Other funds holding NUVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return

Atria Investments's NUVA Position: Q1 2020 in Review

Atria Investments sold out of NuVasive, Inc. (NUVA) in Q1 2020, closing a stake of 2,620 shares — an estimated $203K sold.

Atria Investments first reported a position in NUVA in Q4 2019 and held it in 1 quarter. The position peaked at $203K in Q4 2019. 266 funds tracked by Wall St. Rank hold NUVA as of Q1 2020.

Atria Investments reported no remaining NuVasive, Inc. position as of Q1 2020 after selling out during the quarter.
Atria Investments sold 2,620 NuVasive, Inc. shares in Q1 2020, an estimated $203K.
Atria Investments first reported a position in NuVasive, Inc. in Q4 2019 and held it in 1 quarter.
Atria Investments's NuVasive, Inc. position peaked at $203K in Q4 2019.
266 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2020.

Based on Atria Investments's 13F filing for Q1 2020, filed 15 May 2020.